I am both new to investing and valuepickr forum. I would like to get my holdings reviewed - the idea is get feedback from esteemed members and learn from their experiences. Pls take a look and let me know if I am making any obvious mistakes
The basic motivation of investing is to generate wealth over long term (10 years or more). I have kept a mix of both mid caps & large caps - My reasoning is both financial and growth story coming with it. Pls review. Thnx
Large Caps -
Largecap Pharma with little debt - it has ROE of > 30% - so keeping it for compounding purposes.
Largecap IT with little debt - it has ROE of > 25% - so keeping it for compounding purposes. Still feel there is enough juice left in Indian IT story - there are few non-Indian IT professionals left in US/UK (at least the bulk is Indian). So this should play for next decade
Play on growing Indian middle class and consumerism. HUL hires the most from IIMs and still has awesome marketing network. ITC is almost monoply in Indian Cigarette market + increasing commodities presence.
HDFC Bank 5%
Good Banking Network with great past performance
All large caps kept for compounding purposes only - I hope to retain them without any trading for long term
Mid/Small Caps - Plan to hold them for 5 years at least
Atul Auto 5%
Growing urbanisation, no debt comp with good growth, great past performance, Impressed with management’s fairplay etc
Vinati Organics 10%
Indian Monopoly in specialised chemicals, Promoter with long history in chemicals,
They increased their stake recently - so another plus
Kaveri Seeds 12%
Promoter with long history in agrobased products, no debts, good growth, recently entered after price correction
Avanti Feeds 5%
Growing population and consumerism should help marine based food products.
TV Today 5%
Brought more as RK Damani (famous investor) brought a major stake
The Indian media (esp TV news) still has quite scope of growth - they dont need major capex to run - so hopefully should do well.
AIA Engineering 10%
Experienced Indian company in heavy industry, little debt, good growth & ROE
Ajanta Pharma/Alembic Pharma 10%
Wanted to target growthing Indian Pharma companies with less debt, good ROE/ROCE, good topline & bottomline growth
Both of them are at pricey valuations - however, buying them at dips.